Express Scripts Inc

Type: Company
Name: Express Scripts Inc
Nationality: United States
First reported 1 hour ago - Updated 1 hour ago - 1 reports

Some generic drugs have had eye-popping price spikes [Fort Worth Star-Telegram :: ]

April 19--Pharmacist Larry Cowan can flip through his records and spot the generic drugs that have taken big price jumps in the past year or so.There's digoxin, a heart medicine that he used to buy for pennies a pill."Now the price is close to 10 times ... [Published BusinessWeek - 1 hour ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

S&T chancellor to discuss STEM in St. Louis

Dr. Cheryl B. Schrader, chancellor of Missouri University of Science and Technology, will discuss the importance of STEM education (science, technology, engineering and mathematics) during a forum to be held next month in St. Louis. Schrader is part of ... [Published Rolla Daily News - 23 hours ago]
First reported Apr 18 2014 - Updated Apr 18 2014 - 3 reports

Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract

Express Scripts Awarded 7-Year TRICARE Pharmacy Program Contract ... [Published Noodls - Apr 18 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Apr 18 NYT: Specialty Drug Prices “Soaring”

A New York Times article examines a report about specialty drugs, finding that prices are “soaring.”According to the report, while the cost of prescription drugs has lowered for many consumers (in part due to the use of generics), “those who need the ... [Published Ahip Hi-Wire - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 2 reports

Potential Express Scripts (ESRX) Trade Targets 5.50% Return

Apr 17, 2014 (Marketintelligencecenter.com via COMTEX News Network) -- After closing Wednesday at $73.18, Express Scripts Inc ( ESRX ) presents an attractive opportunity to get a 5.50% return in just 65 days, which is an annualized return of 30.89% (for ... [Published PredictWallStreet - Apr 17 2014]
First reported Apr 15 2014 - Updated Apr 16 2014 - 2 reports

Gilead Sciences, Inc. Feeling Sovaldi Pressure From All Sides

One of the sparks that ignited the recent biotech sell-off was the backlash over the cost of Gilead Sciences '  ( NASDAQ: GILD     ) highly effective hepatitis C therapy. While much of the industry needed a reality check, it looks like the market has ... [Published Motley Fool Discussion Boards - Apr 16 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Express Scripts Holding Company Announces First Quarter 2014 Earnings Conference Call

(GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX), the largest pharmacy benefit management company in North America, announced today its intention to release its first quarter earnings on Tuesday, April 29, 2014 after the market closes ... [Published Benzinga.com - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 1 reports

Video: FMHR Final Trade: Express Scripts 'on sale'

The FMHR traders reveal their final trades of the hour. (CNBC) ... [Published NBCNews.com - Apr 15 2014]
First reported Apr 15 2014 - Updated Apr 15 2014 - 2 reports

Daily business briefing: St. Louis execs among nation's highest paid

Some St. Louis executives have landed on the Equilar 100 CEO Pay Study. The median pay for the 100 CEOs on the list was $13.9 million, up 9 percent from last year. Local execs on the list include Emerson CEO David Farr, Boeing's W. James McNerney Jr. ... [Published Belleville News Democrat - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 15 2014 - 4 reports

Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences Inc. for Hep C Combo?

With the release of phase 2 data from Merck   ( NYSE: MRK     ) and phase 3 data from Bristol-Myers Squibb  ( NYSE: BMY     ) , the race for the new hepatitis C combination treatment is heating up.While leader Gilead Sciences ( NASDAQ: GILD     ) waits ... [Published Motley Fool Discussion Boards - Apr 15 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 2 reports

BRIEF: St. Louis CEOs among 100 best-paid in the U.S. [St. Louis Post-Dispatch :: ]

April 14--David Farr, chairman and chief executive officer of St. Louis-based Emerson, was the nation's fifth-highest-paid CEO in 2013, according to the Equilar 100 CEO Pay Study, released Sunday.Farr's compensation -- including base salary, stock and ... [Published BusinessWeek - Apr 14 2014]
First reported Apr 14 2014 - Updated Apr 14 2014 - 2 reports

AHF: Anti-Gilead Drug Pricing Campaign Picks Up Steam

WASHINGTON--(BUSINESS WIRE)--AHF: Anti-Gilead Drug Pricing Campaign Picks Up Steam - Express Scripts forms coalition to refuse to use Sovaldi. ... [Published Business Wire Public Policy/Government News - Apr 14 2014]

Quotes

"For many years, generics went down and down," said Joe Harmison, owner of DFW Prescriptions in Grand Prairie. "Within the last six to 12 months, they've been going up, some really drastically" said Harmison, who said he has operated his pharmacy for 30 years
...in uniform, along with their dependents and also to military retirees," said George Paz, chairman and chief executive officer, Express Scripts. "This award reaffirms the Express Scripts business model that aligns client and beneficiary interests with our commitment to control costs, drive out pharmacy waste and improve health outcomes."
"Nonregulated parts of the business are at least supporting flattish earnings year over year" said Sheryl Skolnick, an analyst at CRT Capital Group...

More Content

All (453) | News (388) | Reports (0) | Blogs (49) | Audio/Video (0) | Fact Sheets (1) | Press Releases (15)
sort by: Date | Relevance
Some generic drugs have had eye-popping price s... [Published BusinessWeek - 1 hour ago]
What’s keeping the generic version of biologic ... [Published PBS - 3 hours ago]
S&T chancellor to discuss STEM in St. Louis [Published Rolla Daily News - 23 hours ago]
Express Scripts Awarded 7-Year TRICARE Pharmacy... [Published Noodls - Apr 18 2014]
Contracts for April 18, 2014 [Published United States Department of Defense - Apr 18 2014]
Express Scripts Awarded 7-Year TRICARE Pharmacy... [Published Nasdaq - Apr 18 2014]
Express Scripts Awarded 7-Year TRICARE Pharmacy... [Published PR Newswire: Policy & Public Interest - Apr 18 2014]
Blockbuster Drug Boycott? What ESI's Sovaldi Th... [Published Medical Marketing And Media - Apr 18 2014]
Apr 18 NYT: Specialty Drug Prices “Soaring” [Published Ahip Hi-Wire - Apr 18 2014]
Students complete Read, Right, & Run Marathon [Published Shelbyville Daily Union - Apr 18 2014]
Hottest Healthcare Stocks Now – SPNC THC RMD PDLI [Published InvestorPlace.com - Apr 18 2014]
UnitedHealth Earnings Fall 5% On ObamaCare, Med... [Published Yahoo! Finance - Apr 17 2014]
Potential Express Scripts (ESRX) Trade Targets ... [Published PredictWallStreet - Apr 17 2014]
Drugstore Wars: Walgreen Vs. CVS [Published Nasdaq - Apr 17 2014]
England sets aside $31M to fund Sovaldi for sic... [Published FiercePharma - Apr 17 2014]
Green Jobs: Executive Moves at Schneider, KACO,... [Published Greentech Media - Apr 17 2014]
Liberty Medical Supply Highlights the Impact of... [Published PR Newswire: Financial Services - Apr 17 2014]
Letter: Figures disputed [Published Lawrence Journal-World - Apr 17 2014]
Potential Express Scripts (ESRX) Trade Targets ... [Published MarketIntelligenceCenter.com - Apr 17 2014]
Bayer Q1 results: UBS expects strong CropScienc... [Published Invezz - Apr 17 2014]
Hottest Healthcare Stocks Now – LCI LGND AGN ACT [Published InvestorPlace.com - Apr 17 2014]
Gilead Sciences, Inc. Feeling Sovaldi Pressure ... [Published Motley Fool Discussion Boards - Apr 16 2014]
Benefit Designs Holding Steady: A Look at the P... [Published Employersweb.com - Apr 16 2014]
Amid Outcry, State Seeks Vendors to Administer ... [Published Woodstock-Towne Lake Patch - Apr 16 2014]
The S&P 500's 3 Biggest Biotech Losers of 2014 [Published Motley Fool Discussion Boards - Apr 16 2014]
The US Biotech Drug Pricing Challenge [Published Pharmaceutical Executive - Apr 16 2014]
OneRoof Energy adds Valerie Iwinski as senior V... [Published San Diego Daily Transcript - Apr 16 2014]
Top 5 Companies in the Health Care Services Ind... [Published Comtex SmarTrend - Apr 16 2014]
Gilead: This Baby Has Been Thrown Away With The... [Published Seeking Alpha - Apr 16 2014]
Express Scripts (ESRX) Trading Near $74.65 Resi... [Published MarketIntelligenceCenter.com - Apr 16 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Express Scripts Awarded 7-Year TRICARE Pharmacy... [Published PR Newswire: Policy & Public Interest - Apr 18 2014]
ST. LOUIS, April 18, 2014 /PRNewswire/ -- The U.S. Department of Defense today awarded Express Scripts (NASDAQ: ESRX) administration of the TRICARE Pharmacy Program, Fourth Generation (TPharm4) contract serving approximately 10 million beneficiaries. ...
Liberty Medical Supply Highlights the Impact of... [Published PR Newswire: Financial Services - Apr 17 2014]
PORT ST. LUCIE, Fla., April 17, 2014 /PRNewswire/ -- Liberty Medical Supply, Inc., together with its parent company FGST Investments, Inc., holding company, ATLS Acquisition, LLC., and Polymedica Corporation, the legacy parent company of Liberty Healthcare ...
Potential Express Scripts (ESRX) Trade Targets ... [Published MarketIntelligenceCenter.com - Apr 17 2014]
After closing Wednesday at $73.18, Express Scripts Inc (ESRX) presents an attractive opportunity to get a 5.50% return in just 65 days, which is an annualized return of 30.89% (for comparison purposes only). To enter this trade, sell one Jun. '14 $75.00 ...
Express Scripts (ESRX) Trading Near $74.65 Resi... [Published MarketIntelligenceCenter.com - Apr 16 2014]
For a hedged play on Express Scripts Inc (ESRX) MarketIntelligenceCenter.com’s patented trade-picking algorithms selected a Jun. '14 $75.00 covered call for a net debit in the $71.28 area. That is also the break-even stock price for the covered call. ...
Express Scripts (ESRX) Trading Near $74.39 Resi... [Published MarketIntelligenceCenter.com - Apr 15 2014]
With bearish technical indicators and a 4 STARS (out of 5) buy ranking from Standard & Poor’s, Express Scripts Inc (ESRX) could be an attractive play for investors according to MarketIntelligenceCenter.com's patented option-trade picking algorithms. A ...
1 2 3 4 5 6 7 8 9 10

Press Releases

sort by: Date | Relevance
Campaign for Wider Reach, Clinical Trial Result... [Published Financial Services - Apr 11 2014]
Acquisitions, Trial Study Results, Drug Trend R... [Published Financial Services - Apr 10 2014]
Fitch Affirms Express Scripts at 'BBB'; Outlook... [Published Fitch Ratings Headlines Corporate - Mar 25 2014]
Technical Notes on Equities Reaching New 52-Wee... [Published Financial Services - Mar 12 2014]
Express Scripts Announces Record 4th Quarter Ad... [Published Financial Services - Feb 20 2014]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.